Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
data
2
×
life sciences
national blog main
2
×
national top stories
san francisco blog main
san francisco top stories
studies
adaptive biotechnologies
alicrocumab
american academy of neu
american academy of neurology
bicycle therapeutics
biogen
biopharma
board of directors
boston blog main
boston top stories
bostongene
boulder/denver blog main
boulder/denver top stories
canaan partners
clinical study
clinical trials
contepo
dementia
democrats
detroit blog main
detroit top stories
disease
eisai
enzyme
fbi raid
fda
fosfomycin
g1 thearpeutics
gag
gene editing
gene therapy
genome editing
What
america
benefit
bio
biogen
continues
convoluted
democrats
dreams
editing
gene
going
head
headaches
healthcare
holding
humans
insurance
ipo
isn't
landmark
little
medicine
morning
moves
nasdaq
phase
previews
private
public
reported
reports
results
roundup
sangamo
scrutiny
spine
study
suffer
therapeutics
trial
Language
Current search:
data
×
biotech
×
" national blog main "
×
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
